Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Luciano Adorini. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Luciano Adorini har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ICPT / Intercept Pharmaceuticals Inc | Chief Scientific Officer | 649 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Luciano Adorini. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Luciano Adorini som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −649 | 649 | −50,00 | ||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 3 250 | 3 250 | |||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 649 | 12 608 | 5,43 | ||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 1 250 | 11 959 | 11,67 | ||||
2015-07-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −4 000 | 2 923 | −57,78 | ||||
2015-07-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −67 | 0 | −100,00 | ||||
2015-07-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −130 | 10 709 | −1,20 | 243,69 | −31 680 | 2 609 676 | |
2015-07-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −770 | 10 839 | −6,63 | 241,81 | −186 194 | 2 620 979 | |
2015-07-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 000 | 11 609 | −7,93 | 241,57 | −241 571 | 2 804 398 | |
2015-07-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 200 | 12 609 | −8,69 | 240,63 | −288 752 | 3 034 066 | |
2015-07-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −367 | 13 809 | −2,59 | 238,64 | −87 580 | 3 295 341 | |
2015-07-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −600 | 14 176 | −4,06 | 2 538,02 | −1 522 815 | 35 979 037 | |
2015-07-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 000 | 14 776 | 37,12 | 21,50 | 86 000 | 317 684 | |
2015-07-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 67 | 10 776 | 0,63 | 8,67 | 581 | 93 392 | |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −649 | 1 298 | −33,33 | ||||
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 649 | 10 709 | 6,45 | ||||
2015-06-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −4 000 | 67 | −98,35 | ||||
2015-06-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 000 | 10 060 | −16,58 | 250,34 | −500 670 | 2 518 370 | |
2015-06-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 000 | 12 060 | −14,22 | 246,46 | −492 928 | 2 972 357 | |
2015-06-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 000 | 14 060 | 39,76 | 8,67 | 34 667 | 121 854 | |
2015-05-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −4 000 | 0 | −100,00 | ||||
2015-05-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −200 | 10 060 | −1,95 | 262,00 | −52 400 | 2 635 720 | |
2015-05-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 000 | 10 260 | −8,88 | 261,04 | −261 045 | 2 678 322 | |
2015-05-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 000 | 11 260 | −8,16 | 260,00 | −260 000 | 2 927 600 | |
2015-05-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 800 | 12 260 | −12,80 | 259,12 | −466 418 | 3 176 823 | |
2015-05-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 000 | 14 060 | 39,76 | 8,67 | 34 667 | 121 854 | |
2015-04-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −4 000 | 4 000 | −50,00 | ||||
2015-04-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 000 | 10 060 | −16,58 | 271,64 | −543 280 | 2 732 698 | |
2015-04-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 000 | 12 060 | −7,66 | 269,11 | −269 110 | 3 245 467 | |
2015-04-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 000 | 13 060 | −7,11 | 266,18 | −266 180 | 3 476 311 | |
2015-04-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 000 | 14 060 | 39,76 | 8,67 | 34 667 | 121 854 | |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −649 | 1 947 | −25,00 | ||||
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 649 | 10 060 | 6,90 | ||||
2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −649 | 2 596 | −20,00 | ||||
2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 649 | 9 411 | 7,41 | ||||
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −649 | 3 245 | −16,67 | ||||
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 649 | 8 762 | 8,00 | ||||
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −11 038 | 8 000 | −57,98 | |||
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −138 | 8 113 | −1,67 | 346,52 | −47 819 | 2 811 283 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 8 251 | −3,51 | 345,13 | −103 540 | 2 847 695 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 8 551 | −4,47 | 344,00 | −137 599 | 2 941 523 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −203 | 8 951 | −2,22 | 342,69 | −69 566 | 3 067 406 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −497 | 9 154 | −5,15 | 341,90 | −169 926 | 3 129 782 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 9 651 | −3,01 | 340,28 | −102 083 | 3 284 010 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 9 951 | −1,97 | 337,30 | −67 460 | 3 356 455 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 10 151 | −0,98 | 335,14 | −33 514 | 3 402 006 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 10 251 | −0,97 | 332,04 | −33 204 | 3 403 793 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 10 351 | −2,82 | 331,70 | −99 510 | 3 433 427 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 10 651 | −4,48 | 329,95 | −164 974 | 3 514 265 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 11 151 | −3,46 | 328,20 | −131 278 | 3 659 702 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 11 551 | −1,70 | 327,49 | −65 498 | 3 782 837 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 11 751 | −1,67 | 325,66 | −65 131 | 3 826 772 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 11 951 | −0,83 | 322,03 | −32 203 | 3 848 581 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 12 051 | −0,82 | 321,00 | −32 100 | 3 868 371 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 12 151 | −1,62 | 320,20 | −64 041 | 3 890 811 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 12 351 | −2,37 | 319,09 | −95 726 | 3 941 040 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 12 651 | −3,80 | 317,70 | −158 848 | 4 019 172 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −900 | 13 151 | −6,41 | 316,63 | −284 971 | 4 164 059 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 14 051 | −6,64 | 315,01 | −315 008 | 4 426 184 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 100 | 15 051 | −6,81 | 313,71 | −345 076 | 4 721 588 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 16 151 | −5,83 | 312,41 | −312 410 | 5 045 742 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −600 | 17 151 | −3,38 | 311,40 | −186 840 | 5 340 821 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −600 | 17 751 | −3,27 | 310,20 | −186 122 | 5 506 426 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 18 351 | −2,13 | 307,58 | −123 033 | 5 644 424 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 18 751 | −2,09 | 306,49 | −122 597 | 5 747 058 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 11 038 | 19 151 | 136,05 | 8,67 | 95 663 | 165 976 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −649 | 3 894 | −14,29 | ||||
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 649 | 8 113 | 8,70 | ||||
2014-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 0 | −100,00 | |||
2014-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 7 464 | −11,81 | 260,76 | −260 760 | 1 946 313 |
2014-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 8 464 | −10,57 | 258,12 | −258 115 | 2 184 687 |
2014-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 9 464 | 26,80 | 10,40 | 20 800 | 98 427 |
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 2 293 | 2 293 | |||||
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 516 | 516 | |||||
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 423 | 7 464 | 6,01 | ||||
2014-04-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to purchase Common Stock |
M - Exercise | X | −2 000 | 2 000 | −50,00 | |||
2014-04-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 7 041 | −12,44 | 286,30 | −286 300 | 2 015 838 |
2014-04-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 8 041 | −5,85 | 283,00 | −141 500 | 2 275 603 |
2014-04-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 8 541 | −5,53 | 280,00 | −140 000 | 2 391 480 |
2014-04-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 9 041 | 28,41 | 10,40 | 20 800 | 94 027 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −649 | 4 543 | −12,50 | ||||
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 649 | 7 041 | 10,15 | ||||
2014-03-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −2 000 | 4 000 | −33,33 | |||
2014-03-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 000 | 6 392 | −23,83 | 421,31 | −842 620 | 2 693 014 |
2014-03-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 000 | 8 392 | 31,29 | 10,40 | 20 800 | 87 278 |
2014-02-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −2 000 | 6 000 | −25,00 | |||
2014-02-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −500 | 6 392 | −7,25 | 310,04 | −155 020 | 1 981 776 |
2014-02-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −500 | 6 892 | −6,76 | 307,00 | −153 500 | 2 115 844 |
2014-02-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 000 | 7 392 | −11,92 | 301,78 | −301 780 | 2 230 758 |
2014-02-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 000 | 8 392 | 31,29 | 10,40 | 20 800 | 87 278 |
2014-01-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −1 634 | 8 000 | −16,96 | |||
2014-01-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 634 | 6 392 | −20,36 | 67,41 | −110 148 | 430 885 |
2014-01-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 1 634 | 8 026 | 25,56 | 10,40 | 16 994 | 83 471 |
2014-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −649 | 5 192 | −11,11 | ||||
2014-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 649 | 6 392 | 11,30 | ||||
2013-11-25 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −2 000 | 9 634 | −17,19 | |||
2013-11-25 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −380 | 5 743 | −6,21 | 51,26 | −19 477 | 294 359 |
2013-11-25 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 620 | 6 123 | −20,92 | 50,50 | −81 808 | 309 204 |
2013-11-25 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 000 | 7 743 | 34,83 | 10,40 | 20 800 | 80 528 |
2013-10-23 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −2 000 | 11 634 | −14,67 | |||
2013-10-23 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 000 | 5 743 | −25,83 | 55,51 | −111 027 | 318 813 |
2013-10-23 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 000 | 7 743 | 34,83 | 10,40 | 20 800 | 80 528 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −649 | 5 841 | −10,00 | ||||
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 649 | 5 743 | 12,74 | ||||
2013-09-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −2 000 | 13 634 | −12,79 | |||
2013-09-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 000 | 5 094 | −28,19 | 61,07 | −122 134 | 311 075 |
2013-09-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 000 | 7 094 | 39,26 | 10,40 | 20 800 | 73 778 |
2013-08-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −2 000 | 15 634 | −11,34 | |||
2013-08-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 000 | 5 094 | −28,19 | 44,18 | −88 360 | 225 053 |
2013-08-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 000 | 7 094 | 39,26 | 10,40 | 20 800 | 73 778 |
2013-07-24 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −2 000 | 17 634 | −10,19 | |||
2013-07-24 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 000 | 5 094 | −16,41 | 50,34 | −50 342 | 256 441 |
2013-07-24 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 000 | 6 094 | −14,10 | 48,54 | −48 542 | 295 817 |
2013-07-24 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 000 | 7 094 | 39,26 | 10,40 | 20 800 | 73 778 |
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −649 | 6 490 | −9,09 | ||||
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 649 | 5 094 | 14,60 | ||||
2013-06-24 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −2 000 | 19 634 | −9,24 | |||
2013-06-24 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −900 | 4 445 | −16,84 | 37,11 | −33 399 | 164 954 |
2013-06-24 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 5 345 | −3,61 | 37,10 | −7 420 | 198 300 |
2013-06-24 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −400 | 5 545 | −6,73 | 37,04 | −14 816 | 205 387 |
2013-06-24 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 5 945 | −1,65 | 37,01 | −3 701 | 220 024 |
2013-06-24 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −400 | 6 045 | −6,21 | 37,00 | −14 800 | 223 665 |
2013-06-24 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 000 | 6 445 | 44,99 | 10,40 | 20 800 | 67 029 |
2013-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 4 900 | 4 900 | |||||
2013-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
A - Award | 1 200 | 4 445 | 36,98 | ||||
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −3 245 | 7 139 | −31,25 | ||||
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 3 245 | 3 245 | |||||
2012-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 6 923 | 6 923 | |||||
2012-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 10 384 | 10 384 |